enVVeno Medical (NVNO)
(Delayed Data from NSDQ)
$4.77 USD
-0.05 (-1.04%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.78 +0.01 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for enVVeno Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.52 | -24.67 | -16.53 | -9.14 | -7.63 |
Depreciation/Amortization & Depletion | 0.55 | 0.53 | 0.45 | 0.38 | 0.40 |
Net Change from Assets/Liabilities | -0.62 | -0.42 | -1.46 | 0.38 | -0.20 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.73 | 8.95 | 5.69 | 0.70 | 1.53 |
Net Cash From Operating Activities | -18.86 | -15.62 | -11.85 | -7.68 | -5.90 |
Property & Equipment | -0.03 | -0.12 | -0.37 | -0.18 | -0.36 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -7.83 | -34.44 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -7.87 | -34.55 | -0.37 | -0.18 | -0.36 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 25.79 | 0.00 | 19.48 | 14.76 | 5.64 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.31 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 38.13 | 0.00 | 0.00 |
Net Cash from Financing Activities | 25.79 | 0.00 | 57.61 | 15.07 | 5.64 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.94 | -50.17 | 45.39 | 7.22 | -0.62 |
Cash at Beginning of Period | 4.56 | 54.73 | 9.33 | 2.12 | 2.74 |
Cash at End of Period | 3.62 | 4.56 | 54.73 | 9.33 | 2.12 |
Diluted Net EPS | -1.91 | -2.20 | -1.90 | -7.54 | -12.00 |
Fiscal Year End for enVVeno Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4.99 | -23.52 | -17.87 | -12.87 | -6.39 |
Depreciation/Amortization & Depletion | 0.14 | 0.55 | 0.41 | 0.27 | 0.14 |
Net Change from Assets/Liabilities | 0.23 | -0.62 | 0.09 | 0.38 | -0.37 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.07 | 4.73 | 3.49 | 2.54 | 1.52 |
Net Cash From Operating Activities | -3.55 | -18.86 | -13.89 | -9.67 | -5.11 |
Property & Equipment | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.21 | -7.83 | 14.31 | 9.86 | 2.83 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 2.20 | -7.87 | 14.28 | 9.83 | 2.83 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.05 | 25.79 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.05 | 25.79 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.31 | -0.94 | 0.39 | 0.16 | -2.28 |
Cash at Beginning of Period | 3.62 | 4.56 | 4.56 | 4.56 | 4.56 |
Cash at End of Period | 2.31 | 3.62 | 4.95 | 4.71 | 2.27 |
Diluted Net EPS | -0.31 | -0.31 | -0.45 | -0.58 | -0.57 |